Science Explorer Back to mapMap
Discussion
Topic · Epidemiology

Nonmelanoma Skin Cancer Studies

Nonmelanoma Skin Cancer Studies is a research topic within Epidemiology. Science Explorer counts 26k research works in it since 1950. 10.2% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the epidemiology, risk factors, incidence, and management of various types of skin cancers, including nonmelanoma skin cancer, squamous cell carcinoma, and basal cell carcinoma. It also explores the impact of sun exposure, organ transplant recipients, and the use of treatments such as photodynamic therapy and imiquimod cream. The research covers topics related to prevention, diagnosis, and treatment of skin cancer.

  • Skin Cancers
  • Nonmelanoma Skin Cancer
  • Organ Transplant Recipients
  • Actinic Keratoses
  • Squamous Cell Carcinoma
  • Basal Cell Carcinoma
  • Photodynamic Therapy
  • Imiquimod Cream
  • Metastasis
  • Sun Exposure
Research works
26k
fractional, since 1950
In the world top 10%
2.6k
per year above
Top-10% rate
10.2%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
+18%
the tick is no change
Largest producer
United States
37% of the 10 largest, 2022-now
Nonmelanoma Skin Cancer Studies

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Nonmelanoma Skin Cancer Studies research?

By volume, the United States and India publish the most (1.6k and 546 works in 2022-now).

By volume, 2022-now

  1. 1 United States 1.6k works
  2. 2 India 546 works
  3. 3 China 506 works
  4. 4 United Kingdom 285 works
  5. 5 Italy 278 works
  6. 6 Brazil 267 works
  7. 7 Germany 240 works
  8. 8 Spain 211 works
  9. 9 Japan 185 works
  10. 10 Australia 177 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 37.5%India: 12.7%China: 11.7%United Kingdom: 6.6%6 others listed: 31.5%37%largest
United States1,617 · 37.5%India546 · 12.7%China506 · 11.7%United Kingdom285 · 6.6%6 others listed1,358 · 31.5%

Shares of the rows listed above, not of the whole node.

Which institutions lead Nonmelanoma Skin Cancer Studies research?

By volume in 2022-now, Harvard University publishes the most Nonmelanoma Skin Cancer Studies research, followed by Mayo Clinic and University of Miami.

By volume, 2022-now

  1. 1 Harvard UniversityUnited States 64 works
  2. 2 Mayo ClinicUnited States 45 works
  3. 3 University of MiamiUnited States 34 works
  4. 4 All India Institute of Medical SciencesIndia 33 works
  5. 5 The University of Texas MD Anderson Cancer CenterUnited States 32 works
  6. 6 The University of SydneyAustralia 29 works
  7. 7 The University of QueenslandAustralia 27 works
  8. 8 University of PennsylvaniaUnited States 27 works
  9. 9 Memorial Sloan Kettering Cancer CenterUnited States 24 works
  10. 10 Stanford UniversityUnited States 24 works

Who are the leading researchers in Nonmelanoma Skin Cancer Studies?

The most-cited researchers publishing on Nonmelanoma Skin Cancer Studies include Ahmedin Jemal, Freddie Bray and Jacques Ferlay.

  1. 1 Ahmedin Jemal United States 761k citations
  2. 2 Freddie Bray France 550k citations
  3. 3 Jacques Ferlay France 486k citations
  4. 4 Walter Churchill Willett United States 411k citations
  5. 5 Jost Bruno Jonas Germany 350k citations
  6. 6 Hermann Brenner Germany 343k citations
  7. 7 Isabelle Soerjomataram France 327k citations
  8. 8 Charles M. Perou United States 263k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

What are the most cited papers in Nonmelanoma Skin Cancer Studies?

The most cited paper in Nonmelanoma Skin Cancer Studies is "Dermatologist-level classification of skin cancer with deep neural networks" (Andre Esteva, Brett Kuprel, Roberto A. Novoa et al., 2017), with 14,423 citations. Next come "Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck" (5,189) and "Final Version of 2009 AJCC Melanoma Staging and Classification" (4,621).

Most cited papers
#PaperReleasedCitations
1 Dermatologist-level classification of skin cancer with deep neural networks Andre Esteva, Brett Kuprel, Roberto A. Novoa et al. · Nature Open access 25 Jan 2017 14,423
2 Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck Robert Louis Ferris et al. · New England Journal of Medicine Open access 9 Oct 2016 5,189
3 Final Version of 2009 AJCC Melanoma Staging and Classification Charles M. Balch, Jeffrey E. Gershenwald, Seng-Jaw Soong et al. · Journal of Clinical Oncology Open access 16 Nov 2009 4,621
4 Seria cultivation of strains of human epidemal keratinocytes: the formation keratinizin colonies from single cell is James G. Rheinwatd, Howard Green · Cell Nov 1975 4,552
5 Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients Jean‐Pierre Pignon, Aurélie Le Maître, E. Maillard et al. · Radiotherapy and Oncology Review 15 May 2009 3,081
All 100 most cited papers, with filters and sorting

Where is Nonmelanoma Skin Cancer Studies research done?

The largest centres of Nonmelanoma Skin Cancer Studies research in 2022-now are New York (United States), London (United Kingdom), São Paulo (Brazil) and Shanghai (China). Among places with at least 20 works in it, it is an unusually large share of all research in Coral Gables and Omaha.

Largest cities, 2022-now

  1. 1 New YorkUnited States 94 works
  2. 2 LondonUnited Kingdom 76 works
  3. 3 São PauloBrazil 63 works
  4. 4 ShanghaiChina 60 works
  5. 5 HoustonUnited States 59 works
  6. 6 BostonUnited States 57 works
  7. 7 ChennaiIndia 57 works
  8. 8 BeijingChina 53 works
  9. 9 PhiladelphiaUnited States 52 works
  10. 10 RomeItaly 51 works

Where it is the local speciality

  1. Coral GablesUS · 28.3 works9.6×
  2. OmahaUS · 21.5 works7.2×
← less than its size predicts1×more →

Location quotient: how much more of its research is in Nonmelanoma Skin Cancer Studies than the world average.

See Nonmelanoma Skin Cancer Studies on the map

Where is the best place to study Nonmelanoma Skin Cancer Studies?

Among universities, judged by research, Harvard University, The University of Sydney and University of Miami score highest, combining citation excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%10%20%mean 16.9%fractional works in this field (log) →share of work in the world top 10% →Harvard UniversityThe University of Qu…The University of Sy…University of Miami
above the meannear itbelow it

One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.

Citation excellenceshare of its work in the world top 10%, 2022-now and all time averaged
40%
Specialisationhow much of its work is in this field, counted up to 10× the world share
10%
Sizeits output in this field, on a log scale
30%
Growthoutput growth, counted from -20% to +20%
10%
Internationalshare of its work with a co-author abroad
10%
Each slider sets a weight; the share it gets of the score is beside it.
#UniversityScoreTop 10%SpecialisationWorksGrowth
1Harvard UniversityUnited States 74.616.1%3.7×64 -18.3%
2The University of SydneyAustralia 69.513.4%4.4×29 +12.9%
3University of MiamiUnited States 64.711.8%10.2×34 +48.6%
4The University of QueenslandAustralia 64.314.4%5.2×27 -2.3%
5Stanford UniversityUnited States 64.313.1%3.0×24 +11.1%
6Università Cattolica del Sacro CuoreItaly 63.417.0%6.5×15 +42.7%
7Université Libre de BruxellesBelgium 62.919.0%7.5×13 +177.2%
8University of CopenhagenDenmark 62.718.9%3.2×16 -3.8%
9Tongji UniversityChina 57.421.8%1.2×10 +42.5%
10University of GothenburgSweden 57.423.5%3.7×10 -6.6%

Universities only. The score blends citation excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.

Every institution in Nonmelanoma Skin Cancer Studies, country by country

Is Nonmelanoma Skin Cancer Studies research growing?

Output in 2022-2025 was 18% higher than in 2018-2021, peaking in 2025. The fastest-growing topics are Nonmelanoma Skin Cancer Studies.

still counting19801990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Nonmelanoma Skin Cancer Studies as a percentage of every work published that year, 0.025% in 2024.

still counting0.010%0.020%0.030%Nonmelanoma Skin Cancer Studies0.026% in 202519801990200020102020

Fractional works of Nonmelanoma Skin Cancer Studies over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year.

still counting5%10%15%Nonmelanoma Skin Cancer Studies10.2% in 2025200020102020

Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.

Discussion

Ask a question or share a note about Nonmelanoma Skin Cancer Studies. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.